Your browser doesn't support javascript.
Successful Treatment of Persistent Coronavirus Disease 2019 Infection in a Patient With Hypogammaglobulinemia With REGN-COV2: A Case Report.
Luitel, Pankaj; Vais, Dana; Gidron, Adi.
  • Luitel P; Department of Internal Medicine, Amita Saint Francis Hospital Evanston, Evanston, Illinois, USA.
  • Vais D; Department of Infectious Disease, Amita Saint Mary and Elizabeth Hospital Chicago, Chicago, Illinois, USA.
  • Gidron A; Department of Hematology-Oncology, Amita Saint Francis Hospital Evanston, Evanston, Illinois, USA.
Open Forum Infect Dis ; 8(8): ofab335, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1361797
ABSTRACT
A 55-year-old man with hypogammaglobulinemia due to previous rituximab treatment developed persistent coronavirus disease 2019 pneumonia. Treatment with REGN-COV2 (casirivimab and imdevimab) resulted in the clearance of the infection. Targeted antiviral antibodies may be an important weapon in the management of immunocompromised patients infected with severe acute respiratory syndrome coronavirus 2 who fail to mount an immune response.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid